Combination ATR and PARP Inhibitor (CAPRI) Trial With AZD6738 and Olaparib in Recurrent Ovarian Cancer
Clinical trial NCT03462342 · COMPLETED
Trial details
- NCT number
- NCT03462342
- Sponsor
- University of Pennsylvania
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2018-03-09
- Primary completion
- 2025-07-21
- Enrollment
- 123
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.